Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
65
ULBI Quote, Financials, Valuation and Earnings
Last price:
$8.83
Seasonality move
:
-0.68%
Day range:
$8.35 - $8.72
52-week range:
$4.07 - $12.40
Dividend yield:
0%
P/E ratio:
26.88x
P/S ratio:
0.83x
P/B ratio:
1.05x
Volume:
41.1K
Avg. volume:
153.7K
1-year change:
-26.87%
Market cap:
$143M
Revenue:
$164.5M
EPS (TTM):
$0.32
Earnings Data
Next earnings date for ULBI
Jul 25
2025
Most recent earnings per share
$0.11
Missed by $0.04
(May 9/2025)
Consensus Estimate
$0.15
(May 9/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ULBI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $53M | -- | -- | $0.22 | -- |
| 07/25/2025 | Q2 | $51M | -- | -- | $0.14 | -- |
| 05/09/2025 | Q1 | $48M | $50.7M | $0.11 | $0.15 | -$0.04 |
| 03/11/2025 | Q4 | $40M | $43.9M | $0.01 | $0.15 | -$0.14 |
| 11/08/2024 | Q3 | $42.5M | $35.7M | $0.02 | $0.21 | -$0.19 |
| 07/25/2024 | Q2 | $42M | $43M | $0.18 | $0.14 | $0.04 |
| 04/25/2024 | Q1 | $38M | $41.9M | $0.18 | $0.10 | $0.08 |
| 02/15/2024 | Q4 | -- | $44.5M | $0.17 | -- | -- |
| 10/26/2023 | Q3 | -- | -- | $0.08 | $0.10 | -$0.02 |
| 07/27/2023 | Q2 | -- | -- | $0.21 | $0.04 | $0.17 |
| 04/27/2023 | Q1 | -- | -- | -$0.02 | -$0.09 | $0.07 |
| 03/02/2023 | Q4 | -- | -- | -$0.01 | -- | -- |
| 10/27/2022 | Q3 | -- | -- | -$0.01 | $0.06 | -$0.07 |
| 07/28/2022 | Q2 | -- | -- | $0.03 | $0.02 | $0.01 |
| 04/28/2022 | Q1 | -- | -- | -$0.01 | -$0.05 | $0.04 |
| 02/03/2022 | Q4 | -- | -- | -$0.07 | -$0.04 | -$0.03 |
| 10/28/2021 | Q3 | -- | -- | -$0.04 | $0.08 | -$0.12 |
| 07/29/2021 | Q2 | -- | -- | $0.05 | $0.09 | -$0.04 |
| 04/29/2021 | Q1 | -- | -- | $0.04 | $0.06 | -$0.02 |
| 02/04/2021 | Q4 | -- | -- | $0.13 | -- | -- |
| 10/29/2020 | Q3 | -- | -- | $0.03 | -- | -- |
| 07/30/2020 | Q2 | -- | -- | $0.10 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | $0.07 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $0.10 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | $0.06 | -- | -- |
| 05/04/2017 | Q1 | -- | -- | -- | -- | -- |
| 02/09/2017 | Q4 | -- | -- | $0.11 | -- | -- |
| 10/27/2016 | Q3 | -- | -- | $0.07 | -- | -- |
| 07/28/2016 | Q2 | -- | -- | $0.03 | -- | -- |
| 04/27/2016 | Q1 | -- | -- | $0.04 | -- | -- |
| 02/11/2016 | Q4 | -- | -- | $0.03 | -- | -- |
| 10/29/2015 | Q3 | -- | -- | $0.07 | -- | -- |
Ultralife Earnings Questions
-
How Much did Ultralife Generate in Revenue Last Quarter?
Ultralife reported $50.7M worth of top line sales in its most recent quarter.
-
Did Ultralife Beat Earnings Last Quarter?
Ultralife announced earnings per share of $0.11 which represents a miss of analyst forecast a $0.15 per share.
-
Is Ultralife Profitable?
Ultralife reported $12.7M that represents $0.76 per share over the last quarter.
-
What is the Analyst Consensus for Ultralife EPS Next Year?
Ultralife's earnings are forecast to grow from $0.38 per share to $0.57 per share next year representing an increase of 100%.
-
When is Ultralife's Earnings Date?
Ultralife's next earnings date is July 25, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
